Studies have shown that a synthesized PHD inhibitor promotes tissue recovery in murine colitis (DeFrates et al.2024), while butyrate directly inhibits PHD (Wang et al.2021), highlighting its potential therapeutic effects on IBD. Here, PDC is linked to inflammatory bowel disease.